MECHANISMS OF CELLULAR-RESISTANCE TO CYTOTOXIC DRUGS AND X-IRRADIATION - KEYNOTE ADDRESS

被引:19
作者
CARMICHAEL, J [1 ]
HICKSON, ID [1 ]
机构
[1] JOHN RADCLIFFE HOSP, IMPERIAL CANC RES FUND, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 20卷 / 02期
关键词
CHEMOTHERAPY RESISTANCE; RADIATION RESISTANCE; DETOXIFICATION; DNA REPAIR; TOPOISOMERASES;
D O I
10.1016/0360-3016(91)90089-M
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lack of response to X-irradiation and cytotoxic chemotherapy is the major cause of treatment failure in patients with cancer. However, "resistance" to these modalities may be considered a normal cellular response. The ability to cure patients with particular tumor types may be related to hypersensitivity to these modalities caused by loss or abnormality of certain normal cellular constituents such as enzymes involved in DNA repair. It is likely that the initial chemo or radiosensitivity of a tumor will broadly reflect the intrinsic resistance of the tissue type from which the tumor arose. There are many cellular biochemical mechanisms responsible for this relative resistance to drugs and radiation. Many of these mechanisms, although present in normal tissues, may be inducible and can result in enhanced resistance to DNA damaging agents. Although certain resistance mechanisms would appear to be specific for drug resistance or for radiation resistance, there are other resistance mechanisms that potentially affect both modalities. In particular, the study of DNA repair genes in mammalian cells may give us greater insight into common mechanisms of resistance to these modalities.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 43 条
  • [31] RICHON VM, 1987, CANCER RES, V47, P2056
  • [32] MULTIDRUG RESISTANCE - MOLECULAR-BIOLOGY AND CLINICAL RELEVANCE
    ROTHENBERG, M
    LING, V
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (12): : 907 - 910
  • [33] RUSSO A, 1985, CANCER TREAT REP, V69, P1293
  • [34] MECHANISMS OF RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM (II) IN A RAT OVARIAN-CARCINOMA CELL-LINE
    SEKIYA, S
    OOSAKI, T
    ANDOH, S
    SUZUKI, N
    AKABOSHI, M
    TAKAMIZAWA, H
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 429 - 437
  • [35] THE RAS ONCOGENES INCREASE THE INTRINSIC RESISTANCE OF NIH-3T3 CELLS TO IONIZING-RADIATION
    SKLAR, MD
    [J]. SCIENCE, 1988, 239 (4840) : 645 - 647
  • [36] PURIFICATION AND CHARACTERIZATION OF AN ALTERED TOPOISOMERASE-II FROM A DRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE
    SULLIVAN, DM
    LATHAM, MD
    ROWE, TC
    ROSS, WE
    [J]. BIOCHEMISTRY, 1989, 28 (13) : 5680 - 5687
  • [37] NONPRODUCTIVE REARRANGEMENT OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II GENES - CORRELATION WITH RESISTANCE TO TOPOISOMERASE INHIBITORS
    TAN, KB
    MATTERN, MR
    ENG, WK
    MCCABE, FL
    JOHNSON, RK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22) : 1732 - 1735
  • [38] ISOLATION AND STRUCTURAL CHARACTERIZATION OF A CDNA CLONE ENCODING THE HUMAN DNA-REPAIR PROTEIN FOR O-6-ALKYLGUANINE
    TANO, K
    SHIOTA, S
    COLLIER, J
    FOOTE, RS
    MITRA, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 686 - 690
  • [39] TEICHER BA, 1987, CANCER RES, V47, P388
  • [40] WALKER GC, 1985, ANNU REV BIOCHEM, V54, P425, DOI 10.1146/annurev.biochem.54.1.425